Shanghai Zhongshan Hospital
873
164
199
136
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
1.1%
10 terminated/withdrawn out of 873 trials
93.2%
+6.6% vs industry average
12%
101 trials in Phase 3/4
2%
3 of 136 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (873)
LineMatrix® Biological Vascular Graft for Infra-renal Arterial Bypass or Replacement
Role: lead
QL1706（Iparomlimab/Tuvonralimab) Combined With Gemcitabine and Cisplatin as First-Line Treatment for PD-L1-Positive Biliary Tract Cancer
Role: lead
Peripheral Blood Biomarkers and Response to Atezolizumab Plus Bevacizumab in Hepatocellular Carcinoma
Role: lead
Impact of 3D-EIT-Guided Acapella Breathing Training on Lung Ventilation Distribution
Role: lead
Evaluate the Diagnostic Efficacy and Safety of INR 202 PET/CT Imaging in Participants With Advanced Solid Tumors
Role: lead
The Efficacy and Safety of Donafenib Plus PD-1/L1 Monoclonal Antibodies Plus TACE or HAIC as First-line Treatment for Unresectable Hepatocellular Carcinoma A Multi-center, Retrospective Clinical Study
Role: lead
Percutaneous Electrocoagulation Versus Sclerosing Foam for Patients With Incompetent Perforating Veins
Role: collaborator
Efficacy of Lipoic Acid on Chronic Ischemic Heart Failure Patients
Role: lead
Extraperitoneal SINgle-port rObotic-assisted Radical Prostatectomy (RARP) Versus Transperitoneal Multi-port RARP in the Treatment Of Prostate Cancer (SINO-TOP)
Role: collaborator
Phase Ib/II Multicenter Randomized Control Study of Peri-operative Treatment With Combination of CTLA-4, PD-1 Antibodies and Bevacizumab in Resectable HCC (Prophet)
Role: lead
Camrelizumab Combined With Rivoceranib and Hepatic Arterial Infusion Chemotherapy (HAIC) as Conversion Therapy for Potentially Resectable Hepatocellular Carcinoma(HCC)
Role: lead
PregnAncy-Related Aortic DISsEction in China
Role: collaborator
Current Status and Determinants of Care for Patients With Acute Chest Pain in China: A Retrospective Analysis of Data From the China Chest Pain Center Registry
Role: collaborator
Impact of Health Lifestyle on Body Weight
Role: lead
A Prospective Observational Study Using the FAM-CAM
Role: lead
The Safety, Efficacy, and Immune Response of Multimodal Thermal Therapy in the Treatment of Malignant Liver Tumors
Role: collaborator
AI-Driven Tumor Response Evaluation for Solid Tumors
Role: lead
Efficacy and Safety of iGlarLixi Versus Standard of Care in a Real-world Adult China Population With Uncontrolled Type 2 Diabetes on Oral Agents
Role: lead
HAIC + DEB-TACE + Toripalimab + Lenvatinib for Unresectable Intrahepatic Cholangiocarcinoma
Role: lead
EIT-Guided Visual Feedback During Incentive Spirometry for Postoperative Atelectasis
Role: lead